Effect of the UK's revised paracetamol poisoning management guidelines on admissions, adverse reactions and costs of treatment

British Journal of Clinical Pharmacology

Volumn 78, Issue 3, 2014, Pages 610-618

  Bateman, D Nicholas ^a   Carroll, Robert ^b   Pettie, Janice ^a   Yamamoto, Takahiro ^c   Elamin, Muhammad E M O ^d   Peart, Lucy ^d   Dow, Margaret ^a   Coyle, Judy ^a   Cranfield, Kristina R ^a   Hook, Christopher ^a   Sandilands, Euan A ^a   Veiraiah, Aravindan ^a   Webb, David ^a,e   Gray, Alasdair ^a   Dargan, Paul I ^c,f   Wood, David M ^c,f   Thomas, Simon H L ^d   Dear, James W ^a,e   Eddleston, Michael ^a,e  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^d NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

acetylcysteine; adverse effects; paracetamol; poisoning; regulation

Indexed keywords

ACETYLCYSTEINE; BIOLOGICAL MARKER; PARACETAMOL; ANTIDOTE;

ADOLESCENT; ADULT; AGED; ANAPHYLAXIS; CLINICAL PROTOCOL; COST BENEFIT ANALYSIS; COST CONTROL; DRUG INFUSION; DRUG INTOXICATION; DRUG OVERDOSE; DRUG SAFETY; FEMALE; HEALTH CARE COST; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; UNITED KINGDOM; VOMITING; CHILD; CLINICAL TRIAL; ECONOMICS; GREAT BRITAIN; HOSPITALIZATION; INFANT; MIDDLE AGED; MULTICENTER STUDY; PRESCHOOL CHILD; PROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; VERY ELDERLY; YOUNG ADULT;

ACETAMINOPHEN; ACETYLCYSTEINE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIDOTES; CHILD; CHILD, PRESCHOOL; FEMALE; GREAT BRITAIN; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; INFANT; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; RISK ASSESSMENT; YOUNG ADULT;

EID: 84898835457     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/bcp.12362     Document Type: Review

References (24)

1. Ferner RE, Dear JW, Bateman DN,. Management of paracetamol poisoning. BMJ 2011; 342: d2218.
2. Heard KJ,. Acetylcysteine for acetaminophen poisoning. N Engl J Med 2008; 359: 285-292.
3. McQuade DJ, Dargan PI, Keep J, Wood MD,. Paracetamol toxicity: what would be the implications of a change in UK treatment guidelines? Eur J Clin Pharmacol 2012; 65: 1541-1547.
4. Thompson G, Fatima SB, Shah N, Kitching G, Waring WS,. Impact of amending the acetylcysteine marketing authorisation on treatment of paracetamol overdose. ISRN Toxicol 2013; 2013: doi: 10.1155/2013/494357.
5. MHRA. Benefit risk profile of acetylcysteine in the management of paracetamol overdose. [Internet]. 2012. Available at: http://www.mhra.gov.uk/ home/groups/pl-p/documents/drugsafetymessage/con184709.pdf (last accessed 13 May 2013).
6. Pakravan N, Simpson KJ, Waring WS, Bates CM, Bateman DN,. Renal injury at first presentation as a predictor for poor outcome in severe paracetamol poisoning referred to a liver transplant unit. Eur J Clin Pharmacol 2009; 65: 163-168.
7. Craig DG, Bates CM, Davidson JS, Martin KG, Hayes PC, Simpson KJ,. Staggered overdose pattern and delay to hospital presentation are associated with adverse outcomes following paracetamol-induced hepatotoxicity. Br J Clin Pharmacol 2012; 73: 285-294.
8. Whyte IM, Francis B, Dawson AH,. Safety and efficacy of intravenous N-acetylcysteine for acetaminophen overdose: analysis of the Hunter Area Toxicology Service (HATS) database. Curr Med Res Opin 2007; 23: 2359-2368. (Pubitemid 350033437)
9. Lynch RM, Robertson R,. Anaphylactoid reactions to intravenous N-acetylcysteine: a prospective case controlled study. Accid Emerg Nurs 2004; 12: 10-15. (Pubitemid 38041234)
10. Waring WS, Pettie JM, Dow MA, Bateman DN,. Paracetamol appears to protect against N-acetylcysteine-induced anaphylactoid reactions. Clin Toxicol 2006; 44: 441-442.
11. Beer C, Pakravan N, Hudson M, Smith LT, Simpson K, Bateman DN, Thomas SH,. Liver unit admission following paracetamol overdose with concentrations below current UK treatment thresholds. QJM 2007; 100: 93-96. (Pubitemid 46332119)
12. Prescott LF, Illingworth RN, Critchley JA, Stewart MJ, Adam RD, Proudfoot AT,. Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine. Lancet 1977; 2: 432-434. (Pubitemid 8167941)
13. Routledge PA, Vale JA, Bateman DN, Johnston GD, Jones A, Judd A, Thomas S, Volans G, Prescott LF, Proudfoot A,. Paracetamol (acetaminophen) poisoning. No need to change current guidelines to accident departments. BMJ 1998; 317: 1609-1610.
14. Pakravan N, Waring WS, Bateman DN,. Risk factors and mechanisms of anaphylactoid reactions to acetylcysteine in acetaminophen overdose. Clin Toxicol 2008; 46: 697-702.
15. Schmidt L,. Identification of patients at risk of anaphylactoid reactions to N-acetylcysteine in the treatment of paracetamol overdos. Clin Toxicol 2013; 51: 467-472.
16. Kerr F, Dawson A, Whyte IM, Buckley N, Murray L, Graudins A, Chan B, Trudinger B,. The Australasian Clinical Toxicology Investigators Collaboration randomized trial of different loading infusion rates of N-acetylcysteine. Ann Emerg Med 2005; 45: 402-408. (Pubitemid 43181007)
17. Waring WS, Stephen AF, Robinson OD, Dow MA, Pettie JM,. Lower incidence of anaphylactoid reactions to N-acetylcysteine in patients with higher acetamonophen concentrations after overdose. Clin Toxicol 2008; 46: 496-500. (Pubitemid 351913757)
18. Bateman DN, Dear JW, Thanacoody HKR, Thomas SHLT, Eddleston M, Sandilands EA, Coyle J, Cooper JG, Rodriguez A, Butcher I, Lewis SC, Vliegenthart AD, Veiraiah A, Webb DJ, Gray A,. Reducing adverse effects from intravenous acetylcysteine treatment of paracetamol poisoning: a randomised controlled trial. Lancet 2014; 383: 697-704. Published online November 28, 2013. http://dx.doi.org/10.1016/S0140-6736(13)62062-0.
19. Rumack BH, Matthew H,. Actaminophen poiosning and toxicity. Paediatrics 1975; 55: 871-876.
20. Gosselin S, Hoffman RS, Juurlink DN, Whyte IM, Yarema M, Caro J,. Treating acetaminophen overdose: thresholds, costs and uncertainties. Clin Toxicol 2013; 51: 130-133.
21. BNF. British National Formulary, 64th edn. London: BMJ Group and RPS Publishing, 2012.
22. Adams RD, Crawford C, Perry L, Thomas SHL, Thompson JP, Vale JA, Eddleston M,. Paracetamol excess related to dental pain in adults-NPIS enquiries pre and post MHRA guideline changes. Clin Toxicol 2014; 52: 391-392.
23. Wood DM, Conran CP, Dargan PI,. ICD-10 coding: poor identification of recreational drug presentations to a large emergency department. Emerg Med J. 2011; 28: 387-389.
24. Antoine DJ, Dear JW, Lewis PS, Platt V, Coyle J, Masson M, Thanacoody RH, Gray AJ, Webb DJ, Moggs JG, Bateman DN, Goldring CE, Park BK,. Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital. Hepatology 2013; 58: 777-787.